Crescita Therapeutics Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Transdermal
      • Topical Delivery
    • OTC, Consumer

Other Names/Subsidiaries

  • INTEGA Skin Sciences Inc.
  • INTEGA Skin Sciences
See more in Biomedtracker

Latest on Crescita Therapeutics Inc.

Scrip

Deal Watch: Visus Begins Charting Its Direction In Ophthalmology With Two Deals

 
• By Joseph Haas, Ian Haydock, and Vibha Ravi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Visus Licenses Drugs From Cella, Delive

Scrip

Asia Deal Watch: LianBio Partners With Pfizer In Greater China, Gets Financial Backing

 
• By Joseph Haas, Ian Haydock, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. LianBio Adds Pfizer To Initial Tie-Ups

Scrip

Deal Watch: Lilly Partners With Avidity On RNA Medicines That Can Target Outside The Liver

 
• By Joseph Haas, Alex Shimmings, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Lilly/Avidity Partnership In

Pink Sheet

Nuvo/Mallinckrodt’s Pennsaid Setback Starts Clock On Generic Launch

 
• By Shirley Haley

A generic challenger to Nuvo Research Inc. ’s first-generation pain-relief cream for osteoarthritis of the knee now may be launched before a follow-on product can gain FDA approval, after regulator